Pathogens resistant to antimicrobial agents - Epidemiology, molecular mechanisms, and clinical management

被引：32

作者：

Kaye, KS

Fraimow, HS

Abrutyn, E

机构：

[1] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Dept Internal Med, Div Infect Dis, Cambridge, MA 02138 USA

[3] Univ Penn, Grad Hosp, Div Infect Dis, Philadelphia, PA 19104 USA

[4] Med Coll Penn & Hahnemann Univ, Sch Med, Dept Med, Philadelphia, PA 19102 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2000年 / 14卷 / 02期

关键词：

D O I：

10.1016/S0891-5520(05)70249-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This article begins with the molecular mechanisms by which resistance traits are conferred and disseminated and then shifts to the molecular epidemiology and clinical management of certain multidrug resistant bacteria.

引用

页码：293 / +

页数：28

共 177 条

[71] Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs:: A 1997 surveillance trial in 102 medical centers in the United States [J].

Jones, RN ;

Pfaller, MA ;

Doern, GV ;

Erwin, ME ;

Hollis, RJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (03) :215-228

[72] Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric Gram-negative Bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes [J].

Jones, RN ;

Pfaller, MA ;

Marshall, SA ;

Hollis, RJ ;

Wilke, WW .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) :187-192

[73]

Kapoor Hema, 1997, Journal of Communicable Diseases, V29, P263

[74] Treatment failure due to extended spectrum beta-lactamase [J].

Karas, JA ;

Pillay, DG ;

Muckart, D ;

Sturm, AW .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) :203-204

[75] Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community [J].

Klare, I ;

Heier, H ;

Claus, H ;

Bohme, G ;

Marin, S ;

Seltmann, G ;

Hakenbeck, R ;

Antanassova, V ;

Witte, W .

MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (03) :265-272

[76] PNEUMOCOCCAL RESISTANCE TO ANTIBIOTICS [J].

KLUGMAN, KP .

CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (02) :171-196

[77] MANAGEMENT OF ANTIBIOTIC-RESISTANT PNEUMOCOCCAL INFECTIONS [J].

KLUGMAN, KP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (02) :191-193

[78] AMINOGLYCOSIDE-INACTIVATING ENZYMES IN CLINICAL ISOLATES OF STREPTOCOCCUS-FAECALIS - EXPLANATION FOR RESISTANCE TO ANTIBIOTIC SYNERGISM [J].

KROGSTAD, DJ ;

KORFHAGEN, TR ;

WENNERSTEN, C ;

SWARTZ, MN ;

PERZYNSKI, S ;

DAVIES, J ;

MOELLERING, RC .

JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (02) :480-486

[79] The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus [J].

Lautenbach, E ;

Schuster, MG ;

Bilker, WB ;

Brennan, PJ .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) :1259-1265

[80] TREATMENT OF PROSTHETIC VALVE ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS WITH MINOCYCLINE [J].

LAWLOR, MT ;

SULLIVAN, MC ;

LEVITZ, RE ;

QUINTILIANI, R ;

NIGHTINGALE, C .

JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :812-814

← 3 4 5 6 7 8 9 10 11 12 →